A temperature excursion in a pharma cold chain doesn’t just spoil product — it delays patient treatment and triggers FDA regulatory investigations. Qeep’s GDP-validated lanes hold a temperature deviation rate under 0.1% across 240 validated corridors.
Pharmaceutical and healthcare freight operates in a regulatory framework with no tolerance for deviation. Good Distribution Practice (GDP) — under FDA 21 CFR and Health Canada Guidelines — requires documented temperature mapping, validated equipment qualification, and unbroken chain-of-custody from manufacturer to patient. A single temperature excursion can trigger product quarantine, FDA field alert reports, and costly batch investigations. Clinical trial materials add further complexity: IMP (Investigational Medicinal Products) require serialized chain-of-custody, blinded labeling protocols, and site-specific delivery windows that align with investigator schedules. Medical devices add FDA QSR (21 CFR Part 820) and Health Canada MDR compliance requirements. Generalist carriers cannot maintain these standards — healthcare shippers need a partner whose standard operating procedures mirror their own quality systems.
From room-temperature oral solids to liquid-nitrogen cryogenics — Qeep’s qualified lanes cover the full pharmaceutical cold-chain spectrum with documented equipment qualification at every tier.
Biologic drugs, vaccines, and specialty pharma products can be destroyed by a two-hour temperature excursion — sometimes worth millions of dollars per batch. Pre-cooling, continuous data-logger monitoring, alarm response protocols, and qualified thermal packaging are non-negotiable for every movement, including the last-mile leg.
Schedule II-V controlled substances require carrier DEA registration (US) or Health Canada Narcotic and Controlled Substances licensing, facility security protocols, two-person verification at delivery, and destruction manifests for returns. A break in the controlled substance chain-of-custody is a DEA reportable event with potential license revocation consequences.
Investigational products must arrive at clinical sites in the correct kit configuration, under blinded conditions, with the correct temperature record, on a date that aligns with patient dosing visits. Late or incorrect deliveries can invalidate data points in a trial, triggering protocol deviations and increasing development timelines by months.
Pharma shipments increasingly move via a combination of road, air, and last-mile courier — each segment managed by a different operator with different equipment qualification levels. Maintaining a validated, documented chain of temperature across handoffs between carriers requires tightly managed SOPs and real-time data-logger retrieval at each handoff point.
Sterile single-use medical devices can be compromised by moisture ingress, package drop damage, or extreme temperature exposure — rendering them unusable and triggering FDA reportable events. Orthopedic implant sets, surgical instruments, and diagnostic equipment each require specific handling protocols that must be documented in the carrier’s quality management system.
Qeep operates 240 validated pharma cold-chain lanes across North America at 2–8°C (refrigerated), -20°C (frozen), and ambient-controlled profiles. Each lane carries equipment qualification documentation including trailer IQ/OQ protocols, calibrated data-logger certifications, and pre-cool verification records. Temperature records are available to shippers within four hours of delivery.
We maintain a select pool of DEA-registered carriers (US) and Health Canada-licensed transporters (Canada) with validated security protocols: GPS-tracked vehicles with cargo alarm systems, two-person delivery teams for Schedule II shipments, and chain-of-custody documentation that satisfies 21 CFR Part 1301 and NAPRA requirements. Destruction manifest coordination for pharmaceutical returns is included.
Our clinical logistics team manages IMP shipments from sponsor manufacturing sites to investigator sites under blinded conditions. We coordinate with site coordinators on delivery windows tied to patient visit calendars, maintain blinded temperature records, and manage the reverse logistics of unused IMP returns under protocol-specific destruction SOPs.
Sterile medical device shipments move in humidity-controlled environments with drop-height monitoring where required. Our warehouse network includes GMP-grade space with validated storage zones, clean receiving processes, and damage-inspection protocols documented per ISO 13485 quality system expectations. We coordinate OR delivery scheduling with hospital materials management teams.
When a temperature excursion occurs, our quality desk initiates an immediate incident report: data-logger download, root cause analysis documentation, and notification to the shipper’s QP (Qualified Person) within one hour. We maintain full deviation logs and CAPA documentation to support FDA inspection readiness for our pharmaceutical clients.
GDP. DEA. FSMA. ICH Q10. No teaching a generalist what pharma freight must clear. We already know.
Reefer FTL and LTL with continuous temperature logging — frozen, chilled, ambient or multi-temp.
Explore →Time-critical freight — sprinter, straight-truck and team-driver expedites with under-hour cover.
Explore →Bonded and ambient warehousing, pick-and-pack, B2B and DTC fulfillment with WMS visibility.
Explore →Tell us the origin, destination and mode. A Qeep specialist replies within 10 minutes with live capacity, lane price, and a transit window you can actually plan around.
